Abstract: A method includes receiving a drug product package containing one or more drug products therein; evaluating the one or more drug products contained in the drug product package based on a plurality of drug product evaluation factors, the plurality of drug product evaluation factors including an enhanced scrutiny factor; assigning a validation score to the drug product package based on evaluating the one or more drug products contained in the drug product package, a magnitude of the validation score being greater with decreasing patient risk; and validating the drug product package.

Abstract: A method includes receiving an image of a drug product package that contains one or more drug products therein; detecting, using an artificial intelligence engine, characteristics of the image that are associated with a drug product packaging system; and generating a modified image of the drug product package based on characteristics of the drug product packaging system.

Abstract: A method includes receiving an image of a drug product package that contains one or more drug products therein, the image including labeling content displayed on a surface thereof; detecting, using an artificial intelligence engine, the labeling content on the surface of the drug product package; and generating a modified image of the drug product package that has the labeling content removed from surface thereof.

Abstract: A method includes receiving a first plurality of batches, each of the first plurality of batches including a plurality of scripts identifying a plurality of drug products, respectively, and each of the first plurality of batches defining a first packaging sequence for the plurality of drug products identified by the plurality of scripts; receiving operational status information for each of a plurality of drug product packaging systems; and organizing, using an artificial intelligence engine, the plurality of scripts from the first plurality of batches into a second plurality of batches based on the operational status information received for each of the plurality of drug product packaging systems, the second plurality of batches defining a second packaging sequence for the plurality of drug products identified by the plurality of scripts.

Abstract: A twist-on connector for electrical wires and the like comprises a hollow plastic shell having an opening at one end, a generally perpendicular closed end wall at the other end thereof, and one or more wing-like torque applicator ribs extending generally radially outwardly in an oblique angular direction from the external surface of the shell. The torque applicator rib or ribs of such configuration to permit flexing or cushion action to applicator's fingers, or torque limiting means during tool application of connector. The inside surface of the shell is provided with a plurality of longitudinally inwardly extending ribs which function to funnel an insert spring which is threaded into the shell, and to reinforce the body of the shell. The inner end of the spring engages an insert torque applicator stop at the closed end of the shell which transfers the torsional forces applied to the shell body to the outer end of the insert spring.